Evidence map›Paper›PMID 38655100›Full record

ArticleJournal of the Endocrine Society2024

Not Only

Luciana Audi Castroneves, Flavia Regina Rotea Mangone, Antonio Marcondes Lerario, Ana Maria da Cunha Mercante, Rafael Loch Batista, Luciana Rodrigues Carvalho Barros, Carla Vaz Ferreira, Evelin Cavalcante Farias, Felipe Augusto Brasileiro Vanderlei, Ana Luiza Maia and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the Endocrine Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Thyroid C-Cell Biology and Oncogenic Transformation.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2025
    Review
  5. Not OnlyJournal of the Endocrine Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Luciana Audi CastronevesEndocrinology, Instituto do Câncer do Estado de São Paulo, São Paulo 01252-000, Brazil.ORCID https://orcid.org/0000-0002-2482-4675
Flavia Regina Rotea MangoneLaboratory of Molecular Genetics, Center for Translational Research in Oncology (LIM-24), Instituto do Câncer do Estado de São Paulo, São Paulo 01252-000, Brazil.ORCID https://orcid.org/0000-0002-1730-9931
Antonio Marcondes LerarioEndocrine Oncology, University of Michigan Ann Arbor 48109, USA.ORCID https://orcid.org/0000-0002-8336-6432
Ana Maria da Cunha MercantePathology, Instituto do Câncer do Estado de São Paulo, São Paulo 01252-000, Brazil.ORCID https://orcid.org/0000-0003-2340-3382
Rafael Loch BatistaEndocrinology, Instituto do Câncer do Estado de São Paulo, São Paulo 01252-000, Brazil.ORCID https://orcid.org/0000-0002-5461-0301
Luciana Rodrigues Carvalho BarrosLaboratory of Molecular Genetics, Center for Translational Research in Oncology (LIM-24), Instituto do Câncer do Estado de São Paulo, São Paulo 01252-000, Brazil.
Carla Vaz FerreiraThyroid Unit, Endocrine Division, Hospital de Clínicas de Porto Alegre, Porto Alegre 90035-903, Brazil.
Evelin Cavalcante FariasEndocrinology, Instituto do Câncer do Estado de São Paulo, São Paulo 01252-000, Brazil.ORCID https://orcid.org/0000-0002-9832-0269
Felipe Augusto Brasileiro VanderleiHead and Neck Surgery, Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo 05403-010, Brazil.ORCID https://orcid.org/0000-0003-2247-2538
Ana Luiza MaiaThyroid Unit, Endocrine Division, Hospital de Clínicas de Porto Alegre, Porto Alegre 90035-903, Brazil.ORCID https://orcid.org/0000-0002-4186-5532
Maria Aparecida NagaiLaboratory of Molecular Genetics, Center for Translational Research in Oncology (LIM-24), Instituto do Câncer do Estado de São Paulo, São Paulo 01252-000, Brazil.ORCID https://orcid.org/0000-0002-0728-4937
Alexander Augusto Lima JorgeGenetic Endocrinology Unit, Cellular and Molecular Endocrinology Laboratory (LIM-25) Faculdade de Medicina da Universidade de São Paulo, São Paulo 01246-903, Brazil.ORCID https://orcid.org/0000-0003-2567-7360
Ana Oliveira HoffEndocrinology, Instituto do Câncer do Estado de São Paulo, São Paulo 01252-000, Brazil.ORCID https://orcid.org/0000-0002-7058-6321
Instituto do Câncer do Estado de São Paulo · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRHospital de Clínicas de Porto Alegre · BRUniversity of Michigan · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: Genetic analysis of sporadic medullary thyroid carcinoma (MTC) has revealed somatic variants in Objective: To uncover potential new somatic or germline drivers, we analyze a distinct cohort of patients with sporadic, very early-onset, and aggressive MTC. Methods: Germline and somatic DNA exome sequencing was performed in 19 patients, previously tested negative for germline Results: Exome sequencing of 19 germline samples confirmed the absence of Conclusion: This study reveals that within a cohort of early-onset nonhereditary MTC,

Indexed as

chromosomal instabilityexomemedullary thyroid carcinomaNF1RET

Identifiers

PMID38655100
PMCPMC11036102
OpenAlexW4393333738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.